Perspective Therapeutics, Inc. (CATX) Misses Q2 EPS by 16c
Tweet
Share
E-mailGet Alerts CATX Hot Sheet
Join SI Premium – FREE
Perspective Therapeutics, Inc. (NYSE: CATX) reported Q2 EPS of ($0.18), $0.16 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $530 thousand versus the consensus estimate of $87.75 thousand.
For earnings history and earnings-related data on Perspective Therapeutics, Inc. (CATX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- loanDepot receives NYSE non-compliance notice over stock price
- BMO Capital Starts Perspective Therapeutics Inc (CATX) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
